Lb Pharmaceuticals (LBRX) Tax Provisions (2024 - 2025)
Lb Pharmaceuticals' quarterly Tax Provisions came in at $1000.0 in Q4 2025, little changed year-on-year from $1000.0 in Q4 2024, and little changed quarter-over-quarter from $1000.0 in Q4 2024.
Lb Pharmaceuticals has reported Tax Provisions for 2 years, with the latest figure at $1000.0 in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions changed 0.0% year-over-year to $1000.0; the trailing twelve-month figure through Mar 2026 stood at $1000.0 (changed N/A YoY), and the FY2025 full-year result was $1000.0, changed 0.0% from the prior year.
- Tax Provisions for Q4 2025 stood at $1000.0, roughly flat from $1000.0 in the prior quarter.
- The five-year high for Tax Provisions was $1000.0 in Q4 2024, with the low at $1000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Lb Pharmaceuticals | 789.92 Mn | 789.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |